High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT
Clinical trial NCT03130582 · COMPLETED
Trial details
- NCT number
- NCT03130582
- Sponsor
- Yang Jun
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2005-11-01
- Primary completion
- 2014-12-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.